As treatment options continue to expand, healthcare providers have an opportunityand a responsibilityto ensure these therapies are used safely, ethically and as part of personalised care
Calcif Tissue Int 114(2):8697 [DOI] [PubMed] [Google Scholar] 14.Gautier JF, Choukem SP, Girard J (2008) Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes
[DOI] [PMC free article] [PubMed] [Google Scholar] 9.Seiwerth S., Milavic M., Vukojevic J., Gojkovic S., Krezic I., Vuletic L.B., Pavlov K.H., Petrovic A., Sikiric S., Vranes H., et al
In addition to the fact that MASLD is the fastest increasing indication for liver transplantation 4 , it has also been associated with significant all-cause mortality and cardiovascular morbidity and mortality